Skip to main content

Antipodean Advisors LLC

SEC CIK
0001512566
Latest filing
Nov 14, 2023

Holdings in Q2 2021

Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.

Institution overview
Positions
8
−2 vs. Q1 2021
Portfolio value
$363.1M
+$39.7M (+12.3%) vs. Q1 2021
Filed
Aug 16, 2021
SEC
Holdings of Antipodean Advisors LLC in Q2 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
CVNACarvana Co.CL A405,000$122.2M33.7%00.0%UnchangedHistory
SESea LtdSPONSORD ADS350,000$96.1M26.5%00.0%UnchangedHistory
CDLXCardlytics, Inc.COM638,800$81.1M22.3%00.0%UnchangedHistory
CLVTClarivate PLCORD SHS1,275,000$35.1M9.7%00.0%UnchangedHistory
ATRAAtara Biotherapeutics, Inc.COM1,000,000$15.6M4.3%00.0%UnchangedHistory
CMAXCareMax, Inc.COM CL A600,000$7.72M2.1%+600,000NewHistory
CLOVClover Health Investments, Corp.COM CL A235,000$3.13M0.9%+235,000NewHistory
LMNDLemonade, Inc.Stock20,000$2.19M0.6%+20,000NewHistory

Sold out since Q1 2021 (5)

Positions held at the end of Q1 2021 that are gone from this filing.

Positions of Antipodean Advisors LLC sold out since Q1 2021
SecurityClassShares in Q1 2021Value in Q1 2021% of portfolio in Q1 2021History
HLFHerbalife Ltd.COM SHS274,600$12.2M3.8%History
GOTUGaotu Techedu Inc.SPONSORED ADS117,284$3.97M1.2%History
FVRRFiverr International Ltd.ORD SHS10,000$2.17M0.7%History
CTEVClaritev CorpCOM344,000$1.91M0.6%History
NKLANikola CorpCOM53,999$750.0K0.2%History